share_log

藥明巨諾-B:董事名單與其角色和職能

JW THERAP-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

HKEX ·  Jul 31, 2024 17:57

Summary by Moomoo AI

藥明巨諾-B(開曼)有限公司於2024年7月31日公布了其董事會成員名單及各自的角色和職能。董事會包括執行董事劉敏先生,非執行董事李怡平醫生(主席)、高星女士、Sungwon Song博士和劉誠博士,以及獨立非執行董事張耀樑先生、何建昌先生和Debra Yu醫生。公司設有四個董事會委員會,包括審核委員會、薪酬委員會、提名委員會和業務發展及策略委員會,並公布了各董事在這些委員會中的職位,其中張耀樑先生、何建昌先生和Debra Yu醫生分別擔任部分委員會的主席。
藥明巨諾-B(開曼)有限公司於2024年7月31日公布了其董事會成員名單及各自的角色和職能。董事會包括執行董事劉敏先生,非執行董事李怡平醫生(主席)、高星女士、Sungwon Song博士和劉誠博士,以及獨立非執行董事張耀樑先生、何建昌先生和Debra Yu醫生。公司設有四個董事會委員會,包括審核委員會、薪酬委員會、提名委員會和業務發展及策略委員會,並公布了各董事在這些委員會中的職位,其中張耀樑先生、何建昌先生和Debra Yu醫生分別擔任部分委員會的主席。
On July 31, 2024, WuXi Biologics (Cayman) Inc. announced the list of its board of directors and their respective roles and functions. The board of directors includes executive director Mr. Liu Min, non-executive directors Dr. Li Yiping (chairman), Ms. Gao Xing, Dr. Sungwon Song, and Dr. Liu Cheng, as well as independent non-executive directors Mr. Zhang Yaoliang, Mr. Ho Kin Cheung, and Dr. Debra Yu. The company has four board committees, including audit committee, remuneration committee, nomination committee, and business development and strategy committee, and announced the positions of each director in these committees. Mr. Zhang Yaoliang, Mr. Ho Kin Cheung, and Dr. Debra Yu respectively serve as the chairman of some of these committees.
On July 31, 2024, WuXi Biologics (Cayman) Inc. announced the list of its board of directors and their respective roles and functions. The board of directors includes executive director Mr. Liu Min, non-executive directors Dr. Li Yiping (chairman), Ms. Gao Xing, Dr. Sungwon Song, and Dr. Liu Cheng, as well as independent non-executive directors Mr. Zhang Yaoliang, Mr. Ho Kin Cheung, and Dr. Debra Yu. The company has four board committees, including audit committee, remuneration committee, nomination committee, and business development and strategy committee, and announced the positions of each director in these committees. Mr. Zhang Yaoliang, Mr. Ho Kin Cheung, and Dr. Debra Yu respectively serve as the chairman of some of these committees.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more